FDA Coronavirus (COVID-19) Update: August 6th, 2020

Silver Spring, MD – The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:

The FDA issued its first warning letter to New Life International and its second warning letter to Fishman Chemical of North Carolina, LLC, both of which distribute chloroquine phosphate products intended to treat disease in aquarium fish.

[Read more]

FDA Coronavirus (COVID-19) Update: May 19th, 2020

Silver Spring, MD – The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response effort to the COVID-19 Coronavirus pandemic:

The FDA issued warning letters to two companies for selling fraudulent COVID-19 Coronavirus products, as part of the agency’s effort to protect consumers.

[Read more]

FDA Coronavirus (COVID-19) Update: April 25th, 2020

Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:

Friday, the FDA issued an immediately in effect guidance, Enforcement Policy for Remote Digital Pathology Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency, to help expand the availability of devices for remote reviewing and reporting of scanned digital images of pathology slides during this public health emergency.

[Read more]

FDA Continues to Accelerate Development of Novel Therapies for COVID-19

Silver Spring, MD – As part of the Trump Administration’s all-hands-on-deck approach across public, academic and private sectors to combat the Coronavirus (COVID-19) pandemic, the U.S. Food and Drug Administration stood up a new program to expedite the development of potentially safe and effective life-saving treatments.

[Read more]

FDA Coronavirus (COVID-19) Update

Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

The FDA is working closely with manufacturers to make sure that they continue to notify the agency of any permanent discontinuance or interruption of drug and biological product manufacturing in a timely manner.

[Read more]

FDA releases Coronavirus Update, Daily Roundup

Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the coronavirus COVID-19 pandemic:

The FDA is facilitating access to convalescent plasma, antibody-rich blood products that are taken from blood donated by people who have recovered from the coronavirus COVID-19 virus, that could shorten the length, or lessen the severity, of the illness.

[Read more]